Logo image of LFMD

LIFEMD INC (LFMD) Stock Fundamental Analysis

NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD

7.44  +0.08 (+1.09%)

After market: 7.3 -0.14 (-1.88%)

Fundamental Rating

3

Taking everything into account, LFMD scores 3 out of 10 in our fundamental rating. LFMD was compared to 37 industry peers in the Health Care Technology industry. Both the profitability and financial health of LFMD have multiple concerns. LFMD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year LFMD has reported negative net income.
LFMD had a positive operating cash flow in the past year.
LFMD had negative earnings in each of the past 5 years.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
LFMD Yearly Net Income VS EBIT VS OCF VS FCFLFMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

LFMD's Return On Assets of -30.34% is in line compared to the rest of the industry. LFMD outperforms 40.54% of its industry peers.
Industry RankSector Rank
ROA -30.34%
ROE N/A
ROIC N/A
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMD Yearly ROA, ROE, ROICLFMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

LFMD's Gross Margin of 88.67% is amongst the best of the industry. LFMD outperforms 94.59% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
LFMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMD Yearly Profit, Operating, Gross MarginsLFMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
Compared to 5 years ago, LFMD has more shares outstanding
Compared to 1 year ago, LFMD has an improved debt to assets ratio.
LFMD Yearly Shares OutstandingLFMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMD Yearly Total Debt VS Total AssetsLFMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.03, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.03, LFMD is in line with its industry, outperforming 48.65% of the companies in the same industry.
The Debt to FCF ratio of LFMD is 3.06, which is a good value as it means it would take LFMD, 3.06 years of fcf income to pay off all of its debts.
LFMD has a Debt to FCF ratio of 3.06. This is in the better half of the industry: LFMD outperforms 78.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.06
Altman-Z -0.03
ROIC/WACCN/A
WACC10.81%
LFMD Yearly LT Debt VS Equity VS FCFLFMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

LFMD has a Current Ratio of 0.81. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.81, LFMD is doing worse than 67.57% of the companies in the same industry.
A Quick Ratio of 0.76 indicates that LFMD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.76, LFMD is doing worse than 70.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.76
LFMD Yearly Current Assets VS Current LiabilitesLFMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.86% over the past year.
The Revenue has grown by 39.27% in the past year. This is a very strong growth!
The Revenue has been growing by 76.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
Revenue 1Y (TTM)39.27%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%43.23%

3.2 Future

The Earnings Per Share is expected to grow by 43.33% on average over the next years. This is a very strong growth
LFMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.96% yearly.
EPS Next Y89.48%
EPS Next 2Y53.28%
EPS Next 3Y43.33%
EPS Next 5YN/A
Revenue Next Year30.74%
Revenue Next 2Y24.63%
Revenue Next 3Y24.96%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LFMD Yearly Revenue VS EstimatesLFMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
LFMD Yearly EPS VS EstimatesLFMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LFMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LFMD Price Earnings VS Forward Price EarningsLFMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

LFMD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 67.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 55.46
EV/EBITDA N/A
LFMD Per share dataLFMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

LFMD's earnings are expected to grow with 43.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.28%
EPS Next 3Y43.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LFMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIFEMD INC

NASDAQ:LFMD (5/1/2025, 8:00:02 PM)

After market: 7.3 -0.14 (-1.88%)

7.44

+0.08 (+1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-10 2025-03-10/amc
Earnings (Next)05-09 2025-05-09/amc
Inst Owners37.55%
Inst Owner Change1.09%
Ins Owners15.43%
Ins Owner Change9.29%
Market Cap331.68M
Analysts81.33
Price Target12.24 (64.52%)
Short Float %17.03%
Short Ratio4.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-14.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.11%
Min EPS beat(2)-15.66%
Max EPS beat(2)61.87%
EPS beat(4)1
Avg EPS beat(4)-5.94%
Min EPS beat(4)-49.02%
Max EPS beat(4)61.87%
EPS beat(8)3
Avg EPS beat(8)-18.05%
EPS beat(12)4
Avg EPS beat(12)-25.11%
EPS beat(16)6
Avg EPS beat(16)-19.78%
Revenue beat(2)1
Avg Revenue beat(2)3.54%
Min Revenue beat(2)-2.71%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)2.94%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)9.78%
Revenue beat(8)6
Avg Revenue beat(8)3.15%
Revenue beat(12)6
Avg Revenue beat(12)-1.03%
Revenue beat(16)6
Avg Revenue beat(16)-1.28%
PT rev (1m)-0.46%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.12%
EPS NY rev (1m)0%
EPS NY rev (3m)-39.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.4%
Revenue NY rev (1m)4.52%
Revenue NY rev (3m)4.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.56
P/FCF 55.46
P/OCF 18.94
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.54
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.13
FCFY1.8%
OCF(TTM)0.39
OCFY5.28%
SpS4.77
BVpS-0.12
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.67%
FCFM 2.82%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score6
Asset Turnover2.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.06
Debt/EBITDA N/A
Cap/Depr 121.5%
Cap/Sales 5.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.76
Altman-Z -0.03
F-Score6
WACC10.81%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.33%
EPS Next Y89.48%
EPS Next 2Y53.28%
EPS Next 3Y43.33%
EPS Next 5YN/A
Revenue 1Y (TTM)39.27%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%43.23%
Revenue Next Year30.74%
Revenue Next 2Y24.63%
Revenue Next 3Y24.96%
Revenue Next 5YN/A
EBIT growth 1Y-11.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year270.51%
EBIT Next 3Y74.07%
EBIT Next 5YN/A
FCF growth 1Y2436.34%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y98.56%
OCF growth 3YN/A
OCF growth 5Y133.93%